These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25791050)

  • 1. [Possibilities of modern imaging technologies in early diagnosis of Alzheimer disease].
    Unschuld PG
    Ther Umsch; 2015 Apr; 72(4):261-9. PubMed ID: 25791050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
    Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
    J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel neuroimaging perspectives in the diagnosis of dementia].
    Jessen F
    Nervenarzt; 2008 Nov; 79 Suppl 3():129-36; quiz 137. PubMed ID: 18830576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians].
    Trombella S; Assal F; Zekry D; Gold G; Giannakopoulos P; Garibotto V; Démonet JF; Frisoni GB
    Rev Med Suisse; 2016 Apr; 12(515):795-8. PubMed ID: 27276723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
    Yun HJ; Kwak K; Lee JM;
    PLoS One; 2015; 10(6):e0129250. PubMed ID: 26061669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid PET-MRI in Alzheimer's Disease Research.
    Mainta IC; Vargas MI; Trombella S; Frisoni GB; Unschuld PG; Garibotto V
    Methods Mol Biol; 2018; 1750():185-200. PubMed ID: 29512073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of MR-less PiB SUVR quantification methods.
    Bourgeat P; Villemagne VL; Dore V; Brown B; Macaulay SL; Martins R; Masters CL; Ames D; Ellis K; Rowe CC; Salvado O; Fripp J;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S159-66. PubMed ID: 25257985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.
    Klupp E; Grimmer T; Tahmasian M; Sorg C; Yakushev I; Yousefi BH; Drzezga A; Förster S
    J Nucl Med; 2015 Mar; 56(3):399-404. PubMed ID: 25678488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imaging diagnosis of Alzheimer's disease].
    Mänz C; Reimold M; Bender B; Bares R; Ernemann U; Horger M
    Rofo; 2012 Dec; 184(12):1079-82. PubMed ID: 23212812
    [No Abstract]   [Full Text] [Related]  

  • 15. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
    Taswell C; Villemagne VL; Yates P; Shimada H; Leyton CE; Ballard KJ; Piguet O; Burrell JR; Hodges JR; Rowe CC
    J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging-based measures of disease progression in clinical trials of disease-modifying drugs for Alzheimer disease.
    Matthews B; Siemers ER; Mozley PD
    Am J Geriatr Psychiatry; 2003; 11(2):146-59. PubMed ID: 12611744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seeing is believing: neuroimaging adds to our understanding of cerebral pathology.
    Small GW; Kepe V; Barrio JR
    Curr Opin Psychiatry; 2006 Nov; 19(6):564-9. PubMed ID: 17012932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
    Bourgeat P; Chételat G; Villemagne VL; Fripp J; Raniga P; Pike K; Acosta O; Szoeke C; Ourselin S; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Salvado O;
    Neurology; 2010 Jan; 74(2):121-7. PubMed ID: 20065247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.